haloperidol

Generic: haloperidol

Labeler: american health packaging
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name haloperidol
Generic Name haloperidol
Labeler american health packaging
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

haloperidol 2 mg/mL

Manufacturer
American Health Packaging

Identifiers & Regulatory

Product NDC 60687-799
Product ID 60687-799_2e1c7e24-1a56-569f-e063-6294a90ad540
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA073037
Listing Expiration 2026-12-31
Marketing Start 2024-04-15

Pharmacologic Class

Established (EPC)
typical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 60687799
Hyphenated Format 60687-799

Supplemental Identifiers

RxCUI
141935
UNII
J6292F8L3D
NUI
N0000180182

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name haloperidol (source: ndc)
Generic Name haloperidol (source: ndc)
Application Number ANDA073037 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/mL
source: ndc
Packaging
  • 10 TRAY in 1 CASE (60687-799-17) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-799-46) / 5 mL in 1 CUP, UNIT-DOSE (60687-799-40)
source: ndc

Packages (1)

Ingredients (1)

haloperidol (2 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2e1c7e24-1a56-569f-e063-6294a90ad540", "openfda": {"nui": ["N0000180182"], "unii": ["J6292F8L3D"], "rxcui": ["141935"], "spl_set_id": ["862d9bcd-aaaf-4b10-9013-f696f4cf9581"], "pharm_class_epc": ["Typical Antipsychotic [EPC]"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "10 TRAY in 1 CASE (60687-799-17)  / 10 CUP, UNIT-DOSE in 1 TRAY (60687-799-46)  / 5 mL in 1 CUP, UNIT-DOSE (60687-799-40)", "package_ndc": "60687-799-17", "marketing_start_date": "20240415"}], "brand_name": "Haloperidol", "product_id": "60687-799_2e1c7e24-1a56-569f-e063-6294a90ad540", "dosage_form": "SOLUTION", "pharm_class": ["Typical Antipsychotic [EPC]"], "product_ndc": "60687-799", "generic_name": "Haloperidol", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Haloperidol", "active_ingredients": [{"name": "HALOPERIDOL", "strength": "2 mg/mL"}], "application_number": "ANDA073037", "marketing_category": "ANDA", "marketing_start_date": "20240415", "listing_expiration_date": "20261231"}